Not available
Quote | Marinus Pharmaceuticals Inc. (NASDAQ:MRNS)
Last: | $1.42 |
---|---|
Change Percent: | 2.78% |
Open: | $1.4 |
Close: | $1.42 |
High: | $1.44 |
Low: | $1.37 |
Volume: | 1,342,598 |
Last Trade Date Time: | 04/25/2024 03:00:00 am |
News | Marinus Pharmaceuticals Inc. (NASDAQ:MRNS)
2024-04-16 10:00:22 ET More on Health Care Select Sector SPDR XLV: Fundamentals Don't Support Overweighting Health Care XLV: Low-Cost Exposure To A Defensive Sector, While Achieving Strong Performance Healthcare In 2024: Navigating The Biopharma Bull Run Shor...
2024-04-16 08:15:04 ET Cantor Fitzgerald analyst issues OVERWEIGHT recommendation for MRNS on April 16, 2024 06:31AM ET. The previous analyst recommendation was Overweight. MRNS was trading at $1.3 at issue of the analyst recommendation. The overall analyst consensus : H...
Message Board Posts | Marinus Pharmaceuticals Inc. (NASDAQ:MRNS)
Subject | By | Source | When |
---|---|---|---|
Did you add more here? This recovered | Cosa | investorshub | 04/19/2023 12:04:13 AM |
whytestocks: $MRNS News Article - Marinus Pharmaceuticals Receives FDA Orphan Drug Designation for G | whytestocks | investorshangout | 03/22/2023 5:10:50 PM |
whytestocks: $MRNS News Article - Marinus Pharmaceuticals Appoints Christine Silverstein to its Boar | whytestocks | investorshangout | 01/30/2023 9:05:45 PM |
Thanks, I will look. | Cosa | investorshub | 01/23/2023 6:34:53 PM |
Ha, our time is coming for MRNS Cosa, | Ganz | investorshub | 01/20/2023 3:40:51 PM |
News, Short Squeeze, Breakout and More Instantly...
Marinus Pharmaceuticals Inc. Company Name:
MRNS Stock Symbol:
NASDAQ Market:
Marinus Pharmaceuticals Inc. Website:
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgr...
Monday, in an interim analysis of Marinus Pharmaceuticals Inc’s (NASDAQ:MRNS) phase 3 RAISE trial, evaluating intravenous (IV) gana...
2024-04-16 08:15:04 ET Cantor Fitzgerald analyst issues OVERWEIGHT recommendation for MRNS on April 16, 2024 06:31AM ET. The previous analyst recommendation was Overweight. MRNS was trading at $1.3 at issue of the analyst recommendation. The overall analyst consensus : H...